QuellTX
Aaron Vernon has a diverse work experience in the field of technical operations and supply chain management. Aaron has held various leadership roles in reputable companies such as Quell Therapeutics, where they serve as the Chief Manufacturing Officer. Additionally, Aaron has also founded and worked as the Principal at ACE Biopharm Consulting LLC. Prior to their current roles, they served as the VP of Technical Operations at TCR² Therapeutics Inc. and VP of Global Technical Operations (a.i.) at Autolus Ltd. Other notable positions include Vice President of Global Supply Chain and Manufacturing at Sucampo Pharmaceuticals, Inc., Director of Supply Chain Operations at AstraZeneca, and various managerial roles at MedImmune. With their extensive experience and expertise, Aaron has proven himself as a valuable asset in the industry.
Aaron Vernon has a diverse education history. Aaron obtained a Bachelor of Science in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania. Aaron also completed a Post Graduate Certificate in Process Business Management from the University of Warwick - WMG. Furthermore, they pursued a Master of Business Administration (MBA) from the University of Maryland Global Campus. Additionally, they obtained a Master's of Technology Management with a focus on Project Management from the same university. Lastly, they attended Rutgers University, where they earned a Master of Science in Mechanical Engineering. Aaron Vernon also attended Georgetown Day School, but no specific degree or field of study was provided for this institution.
This person is not in any offices
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.